Open AccessP991: IMPAIRMENT OF TCR SIGNALLING IN PATIENTS WITH MYELOFIBROSIS TREATED WITH RUXOLITINIB
Author(s) -
Harrington P.,
Dillon R.,
Radia D.,
McLornan D.,
CurtoGarcia N.,
Woodley C.,
Asirvatham S.,
Kordasti S.,
Harrison C.,
Lavallade H.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846832.56792.11
Subject(s) - ruxolitinib , foxp3 , t cell receptor , il 2 receptor , myelofibrosis , flow cytometry , t cell , immunology , immune system , medicine , cancer research , pharmacology , bone marrow